Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2022-12-16 | 2023-01-06 | 178763 |
APO-ABIRATERONE FILM COATED TABLETS | 250MG | TABLET | Resolved | 2022-12-16 | 2023-01-10 | 178769 |
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 1000MG 50MG | TABLET | Resolved | 2022-12-16 | 2023-02-02 | 178778 |
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 1000MG 50MG | TABLET | Resolved | 2022-12-16 | 2023-02-02 | 178781 |
APO-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2022-12-16 | 2023-03-30 | 178784 |
APO-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2022-12-16 | 2023-03-30 | 178787 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 5MG | TABLET | Resolved | 2022-12-16 | 2023-03-02 | 178793 |
APO-FLECAINIDE | 50MG | TABLET | Resolved | 2022-12-23 | 2023-01-13 | 179450 |
APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-12-23 | 2023-02-17 | 179453 |
APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2022-12-23 | 2023-01-26 | 179456 |
APO-PRAVASTATIN | 20MG | TABLET | Resolved | 2022-12-23 | 2023-01-20 | 179459 |
APO-SOTALOL | 80MG | TABLET | Resolved | 2023-01-06 | 2023-02-16 | 180086 |
APO-SOTALOL | 160MG | TABLET | Resolved | 2023-01-06 | 2023-02-16 | 180093 |
APO-VERAP TABLET 120MG | 120MG | TABLET | Resolved | 2023-01-06 | 2023-03-02 | 180106 |
APO-IBUPROFEN | 400MG | TABLET | Resolved | 2023-01-06 | 2023-02-09 | 180109 |
APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2023-01-06 | 2023-02-09 | 180116 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2023-01-06 | 2023-03-30 | 180119 |
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 500MG 50MG | TABLET | Resolved | 2023-01-06 | 2023-07-27 | 180124 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2023-01-13 | 2024-03-22 | 181101 |
APO-RALOXIFENE | 60MG | TABLET | Resolved | 2023-01-13 | 2023-04-21 | 181104 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-03 | 71090 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2019-08-08 | 60420 |
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2018-09-15 | 60438 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-08-07 | 2019-08-07 | 91117 |
APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4909 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-01-04 | 2019-01-04 | 71207 |
APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
APO-ZOLMITRIPTAN RAPID | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-09-08 | 2018-09-15 | 60867 |